bemarituzumab chemotherapy improve outcome in advance gastric and gastroesophageal junction cancer
Published 3 years ago • 172 plays • Length 4:29Download video MP4
Download video MP3
Similar videos
-
9:46
bemarituzumab mfolfox6 in first-line advanced gastric/gastroesophageal junction adenocarcinoma
-
1:35
fight: bemarituzumab mfolfox6 in first-line advanced gastric cancer
-
6:03
fight updates: bemarituzumab with folfox6 in fgfr2b advanced gastric/gastroesophageal junction ...
-
5:26
fight update: 1l bemarituzumab in fgfr2b gastric cancer
-
1:10
keynote-811: hrqol pembro plus tras and chemo in first-line her2 advanced gastric cancer
-
9:58
bemarituzumab plus folfox for advanced gastric/ge junction adenocarcinoma
-
7:45
pembrolizumab alone or with chemotherapy for advanced gastric/ge junction cancer
-
4:06
cancer clinical trials: part 5 - getting support on your clinical trial journey
-
0:54
perioperative pembrolizumab for stomach cancer treatment
-
12:10
role of chemotherapy in esophagus and gastroesophageal junction cancers - evidence based overview
-
1:38:03
clinical trials updates for gastric cancer patients
-
1:37
phase 1b trial of avelumab in advanced gastric or gastroesophageal junction cancer
-
8:01
innovation: chemotherapy with trastuzumab and pertuzumab in her2 gastric cancer
-
6:31
checkmate 649 biomarker analyses of nivo ipi vs chemo for patients with gc/gejc/eac
-
8:25
pembrolizumab comparable to chemotherapy for patients with advanced gastric or gastroesophageal ...
-
2:21
final analysis of keynote-585: pembrolizumab and chemotherapy in g/gej cancer
-
3:03
adjuvant pembrolizumab improves rcc disease-free survival | toni choueiri
-
9:53
chemotherapy, immunotherapy, targeted therapy for gastric cancer, esophageal cancer -edusurg clinics